Journal for ImmunoTherapy of Cancer (Nov 2021)

880 Tetravalent, bispecific innate cell engager AFM24 enhances macrophage mediated tumor cell phagocytosis

Uwe Reusch,
Joachim Koch,
Sheena Pinto,
Susanne Wingert,
Jens Pahl,
Armin Beez,
Sabrina Purr,
Arndt Schottelius

Affiliations

Uwe Reusch: Aff1 Affimed GmbH Heidelberg Germany
Joachim Koch: 4Affimed GmbH, Heidelberg, Germany
Sheena Pinto: Affimed GmH, Heidelberg, Germany
Susanne Wingert: Affimed GmH, Heidelberg, Germany
Jens Pahl: Affimed GmH, Heidelberg, Germany
Armin Beez: Affimed GmH, Heidelberg, Germany
Sabrina Purr: Affimed GmH, Heidelberg, Germany
Arndt Schottelius: Affimed GmH, Heidelberg, Germany

DOI: https://doi.org/10.1136/jitc-2021-SITC2021.880
Journal volume & issue: Vol. 9, no. Suppl 2

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal